6-K ·Filed May 1, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No actionable trading signal. The filing is a routine disclosure of share count and minor employee share issuance. Monitor upcoming earnings or pipeline updates for material catalysts.
Final — all horizons settled through T+60d
AZN ▼ -8.07% at T+60d
NEUTRAL call ✗ call lost -8.07% · α vs SPY -10.63% · entry $184.54 → $169.64
T+1d
-0.65%
call -0.65% · α -0.31%
$183.33
settled 5mo ago
T+5d
-1.00%
call -1.00% · α -3.35%
$182.69
settled 5mo ago
T+20d
-2.62%
call -2.62% · α -7.90%
$179.71
settled 4mo ago
T+60d
-8.07%
call -8.07% · α -10.63%
$169.64
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
AstraZeneca filed a routine 6-K reporting total voting rights as of April 30, 2026 (1,550,995,630 shares) and the admission of 14,807 shares under employee share schemes. This is a standard administrative update with no material financial impact.
Key Facts
- Total voting rights: 1,550,995,630 ordinary shares as of April 30, 2026.
- 14,807 new shares issued under employee share schemes between April 1 and April 30, 2026.
- No shares held in treasury.
- Shares are fully fungible with existing ordinary shares.
Financial Impact
Negligible dilution: 14,807 new shares represent ~0.001% of total shares outstanding.
dilution
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (36 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-004247 |
| Document: 0001654954-26-004247-index-headers.html | 0001654954-26-004247 |
| Document: 0001654954-26-004247-index.html | 0001654954-26-004247 |
| Document: 0001654954-26-004247.txt | 0001654954-26-004247 |
54 reports for AZN
67% Hit rate best @ T+60▲ +13.65%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $161.85 $168.37 | ▲ +4.03% | ▲ +1.90% | $157.02 (−2.98%) |
Sep 14, 2026 18d ago | 6-K | $163.78 $168.10 | ▼ −2.64% | ▼ −2.53% | $157.02 (+4.13%) |
Sep 8, 2026 24d ago | 6-K | $160.04 $161.85 | ▲ +1.13% | ▲ +2.25% | $157.02 (−1.89%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $157.02 (−3.35%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $157.02 (−3.35%) |
Aug 31, 2026 4w ago | Court Ruling | $162.13 $159.95 | ▲ +1.34% | ▲ +1.20% | $157.02 (+3.15%) |
Showing 10 of 54
US Market Status
Market Open — Closes in 35m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access